ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
WT1
|
ENSG00000184937.8 | WT1 |
MTF1
|
ENSG00000188786.9 | MTF1 |
ZBTB7B
|
ENSG00000160685.9 | ZBTB7B |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
WT1 | hg19_v2_chr11_-_32452357_32452363, hg19_v2_chr11_-_32457176_32457193, hg19_v2_chr11_-_32456891_32456906 | -0.74 | 1.1e-03 | Click! |
MTF1 | hg19_v2_chr1_-_38325256_38325292 | -0.33 | 2.1e-01 | Click! |
ZBTB7B | hg19_v2_chr1_+_154975258_154975330 | -0.19 | 4.7e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_235860616 | 22.26 |
ENST00000392011.2 |
SH3BP4 |
SH3-domain binding protein 4 |
chr1_-_20812690 | 18.55 |
ENST00000375078.3 |
CAMK2N1 |
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr3_-_185542817 | 16.16 |
ENST00000382199.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr3_-_185542761 | 15.60 |
ENST00000457616.2 ENST00000346192.3 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr12_-_124457257 | 14.60 |
ENST00000545891.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr16_+_56642489 | 13.70 |
ENST00000561491.1 |
MT2A |
metallothionein 2A |
chr3_-_149688655 | 12.84 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr14_-_53417732 | 12.72 |
ENST00000399304.3 ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2 |
fermitin family member 2 |
chr17_-_882966 | 12.35 |
ENST00000336868.3 |
NXN |
nucleoredoxin |
chr3_-_149688502 | 12.15 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
chr2_-_110371720 | 11.83 |
ENST00000356688.4 |
SEPT10 |
septin 10 |
chr19_-_18717627 | 11.58 |
ENST00000392386.3 |
CRLF1 |
cytokine receptor-like factor 1 |
chr11_-_12030629 | 11.56 |
ENST00000396505.2 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr10_+_124221036 | 11.53 |
ENST00000368984.3 |
HTRA1 |
HtrA serine peptidase 1 |
chr12_-_124457371 | 11.11 |
ENST00000238156.3 ENST00000545037.1 |
CCDC92 |
coiled-coil domain containing 92 |
chr2_-_1748214 | 10.62 |
ENST00000433670.1 ENST00000425171.1 ENST00000252804.4 |
PXDN |
peroxidasin homolog (Drosophila) |
chr16_+_56659687 | 10.33 |
ENST00000568293.1 ENST00000330439.6 |
MT1E |
metallothionein 1E |
chr17_-_76921459 | 10.28 |
ENST00000262768.7 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr1_-_225840747 | 10.21 |
ENST00000366843.2 ENST00000366844.3 |
ENAH |
enabled homolog (Drosophila) |
chr6_+_7541808 | 10.15 |
ENST00000379802.3 |
DSP |
desmoplakin |
chr10_-_126849068 | 9.98 |
ENST00000494626.2 ENST00000337195.5 |
CTBP2 |
C-terminal binding protein 2 |
chr7_+_116166331 | 9.85 |
ENST00000393468.1 ENST00000393467.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr2_-_161264385 | 9.82 |
ENST00000409972.1 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr4_-_157892498 | 9.64 |
ENST00000502773.1 |
PDGFC |
platelet derived growth factor C |
chr16_+_56642041 | 9.59 |
ENST00000245185.5 |
MT2A |
metallothionein 2A |
chr2_+_9346892 | 9.35 |
ENST00000281419.3 ENST00000315273.4 |
ASAP2 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr2_-_110371777 | 9.27 |
ENST00000397712.2 |
SEPT10 |
septin 10 |
chr3_+_37903432 | 9.23 |
ENST00000443503.2 |
CTDSPL |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr6_+_17393839 | 8.93 |
ENST00000489374.1 ENST00000378990.2 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr8_+_136469684 | 8.77 |
ENST00000355849.5 |
KHDRBS3 |
KH domain containing, RNA binding, signal transduction associated 3 |
chr9_+_128509663 | 8.57 |
ENST00000373489.5 ENST00000373483.2 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
chr10_-_735553 | 8.45 |
ENST00000280886.6 ENST00000423550.1 |
DIP2C |
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
chr22_-_50746027 | 8.29 |
ENST00000425954.1 ENST00000449103.1 |
PLXNB2 |
plexin B2 |
chr10_-_126849588 | 8.23 |
ENST00000411419.2 |
CTBP2 |
C-terminal binding protein 2 |
chr6_+_17393888 | 8.19 |
ENST00000493172.1 ENST00000465994.1 |
CAP2 |
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr3_-_124774802 | 8.17 |
ENST00000311127.4 |
HEG1 |
heart development protein with EGF-like domains 1 |
chr2_-_224903995 | 8.15 |
ENST00000409304.1 ENST00000454956.1 ENST00000258405.4 |
SERPINE2 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chr2_-_110371412 | 8.12 |
ENST00000415095.1 ENST00000334001.6 ENST00000437928.1 ENST00000493445.1 ENST00000397714.2 ENST00000461295.1 |
SEPT10 |
septin 10 |
chr22_-_50746001 | 8.05 |
ENST00000359337.4 |
PLXNB2 |
plexin B2 |
chr11_-_12030905 | 8.05 |
ENST00000326932.4 |
DKK3 |
dickkopf WNT signaling pathway inhibitor 3 |
chr2_-_227664474 | 7.97 |
ENST00000305123.5 |
IRS1 |
insulin receptor substrate 1 |
chr3_-_149688896 | 7.92 |
ENST00000239940.7 |
PFN2 |
profilin 2 |
chr9_+_128509624 | 7.89 |
ENST00000342287.5 ENST00000373487.4 |
PBX3 |
pre-B-cell leukemia homeobox 3 |
chr8_+_30241934 | 7.78 |
ENST00000538486.1 |
RBPMS |
RNA binding protein with multiple splicing |
chr1_+_182992545 | 7.74 |
ENST00000258341.4 |
LAMC1 |
laminin, gamma 1 (formerly LAMB2) |
chr13_+_98795505 | 7.72 |
ENST00000319562.6 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr6_+_7541845 | 7.69 |
ENST00000418664.2 |
DSP |
desmoplakin |
chr4_+_88928777 | 7.68 |
ENST00000237596.2 |
PKD2 |
polycystic kidney disease 2 (autosomal dominant) |
chr6_-_3752222 | 7.61 |
ENST00000380283.4 |
PXDC1 |
PX domain containing 1 |
chr7_+_116165754 | 7.58 |
ENST00000405348.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr2_+_241375069 | 7.56 |
ENST00000264039.2 |
GPC1 |
glypican 1 |
chr11_-_2160611 | 7.54 |
ENST00000416167.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr17_-_74707037 | 7.52 |
ENST00000355797.3 ENST00000375036.2 ENST00000449428.2 |
MXRA7 |
matrix-remodelling associated 7 |
chrX_+_102631844 | 7.40 |
ENST00000372634.1 ENST00000299872.7 |
NGFRAP1 |
nerve growth factor receptor (TNFRSF16) associated protein 1 |
chrX_+_135229600 | 7.40 |
ENST00000370690.3 |
FHL1 |
four and a half LIM domains 1 |
chr5_-_16936340 | 7.31 |
ENST00000507288.1 ENST00000513610.1 |
MYO10 |
myosin X |
chr1_+_169075554 | 7.30 |
ENST00000367815.4 |
ATP1B1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
chr22_-_38794490 | 7.28 |
ENST00000400206.2 |
CSNK1E |
casein kinase 1, epsilon |
chr8_-_11725549 | 7.25 |
ENST00000505496.2 ENST00000534636.1 ENST00000524500.1 ENST00000345125.3 ENST00000453527.2 ENST00000527215.2 ENST00000532392.1 ENST00000533455.1 ENST00000534510.1 ENST00000530640.2 ENST00000531089.1 ENST00000532656.2 ENST00000531502.1 ENST00000434271.1 ENST00000353047.6 |
CTSB |
cathepsin B |
chr16_-_56701933 | 7.21 |
ENST00000568675.1 ENST00000569500.1 ENST00000444837.2 ENST00000379811.3 |
MT1G |
metallothionein 1G |
chr13_+_98795434 | 7.18 |
ENST00000376586.2 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr5_+_52776228 | 7.15 |
ENST00000256759.3 |
FST |
follistatin |
chr16_+_56685796 | 7.14 |
ENST00000334346.2 ENST00000562399.1 |
MT1B |
metallothionein 1B |
chr4_-_177713788 | 7.13 |
ENST00000280193.2 |
VEGFC |
vascular endothelial growth factor C |
chr11_+_69455855 | 7.12 |
ENST00000227507.2 ENST00000536559.1 |
CCND1 |
cyclin D1 |
chr2_-_110371664 | 7.04 |
ENST00000545389.1 ENST00000423520.1 |
SEPT10 |
septin 10 |
chr20_-_50385138 | 7.03 |
ENST00000338821.5 |
ATP9A |
ATPase, class II, type 9A |
chr16_+_56691606 | 6.98 |
ENST00000334350.6 |
MT1F |
metallothionein 1F |
chr14_-_69446034 | 6.97 |
ENST00000193403.6 |
ACTN1 |
actinin, alpha 1 |
chr21_+_46825032 | 6.94 |
ENST00000400337.2 |
COL18A1 |
collagen, type XVIII, alpha 1 |
chr13_-_110438914 | 6.93 |
ENST00000375856.3 |
IRS2 |
insulin receptor substrate 2 |
chr14_-_69445968 | 6.90 |
ENST00000438964.2 |
ACTN1 |
actinin, alpha 1 |
chr11_-_2160180 | 6.81 |
ENST00000381406.4 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr17_-_78009647 | 6.80 |
ENST00000310924.2 |
TBC1D16 |
TBC1 domain family, member 16 |
chr1_-_95392635 | 6.76 |
ENST00000538964.1 ENST00000394202.4 ENST00000370206.4 |
CNN3 |
calponin 3, acidic |
chr8_+_30241995 | 6.64 |
ENST00000397323.4 ENST00000339877.4 ENST00000320203.4 ENST00000287771.5 |
RBPMS |
RNA binding protein with multiple splicing |
chr10_-_79397391 | 6.62 |
ENST00000286628.8 ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr12_+_6309517 | 6.62 |
ENST00000382519.4 ENST00000009180.4 |
CD9 |
CD9 molecule |
chr3_-_134093275 | 6.60 |
ENST00000513145.1 ENST00000422605.2 |
AMOTL2 |
angiomotin like 2 |
chr2_+_36582857 | 6.50 |
ENST00000280527.2 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
chr19_-_19051927 | 6.37 |
ENST00000600077.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr1_-_93426998 | 6.36 |
ENST00000370310.4 |
FAM69A |
family with sequence similarity 69, member A |
chr11_+_19798964 | 6.29 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
chr9_-_99381660 | 6.28 |
ENST00000375240.3 ENST00000463569.1 |
CDC14B |
cell division cycle 14B |
chr10_-_125851961 | 6.24 |
ENST00000346248.5 |
CHST15 |
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr2_+_201171064 | 6.22 |
ENST00000451764.2 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr2_-_161350305 | 6.22 |
ENST00000348849.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr8_+_94929168 | 6.20 |
ENST00000518107.1 ENST00000396200.3 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chrX_+_135229731 | 6.18 |
ENST00000420362.1 |
FHL1 |
four and a half LIM domains 1 |
chr11_-_65640325 | 6.13 |
ENST00000307998.6 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
chr4_+_38869410 | 6.11 |
ENST00000358869.2 |
FAM114A1 |
family with sequence similarity 114, member A1 |
chr15_+_80696666 | 6.10 |
ENST00000303329.4 |
ARNT2 |
aryl-hydrocarbon receptor nuclear translocator 2 |
chr3_+_12329397 | 6.09 |
ENST00000397015.2 |
PPARG |
peroxisome proliferator-activated receptor gamma |
chr2_+_201171372 | 6.07 |
ENST00000409140.3 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr11_-_65640198 | 6.04 |
ENST00000528176.1 |
EFEMP2 |
EGF containing fibulin-like extracellular matrix protein 2 |
chr2_+_20646824 | 6.04 |
ENST00000272233.4 |
RHOB |
ras homolog family member B |
chr5_-_127873659 | 6.02 |
ENST00000262464.4 |
FBN2 |
fibrillin 2 |
chr16_+_3068393 | 6.02 |
ENST00000573001.1 |
TNFRSF12A |
tumor necrosis factor receptor superfamily, member 12A |
chr16_+_56703703 | 5.93 |
ENST00000332374.4 |
MT1H |
metallothionein 1H |
chr2_+_46524537 | 5.90 |
ENST00000263734.3 |
EPAS1 |
endothelial PAS domain protein 1 |
chr14_-_75079026 | 5.88 |
ENST00000261978.4 |
LTBP2 |
latent transforming growth factor beta binding protein 2 |
chr8_-_67525473 | 5.88 |
ENST00000522677.3 |
MYBL1 |
v-myb avian myeloblastosis viral oncogene homolog-like 1 |
chr14_-_69445793 | 5.79 |
ENST00000538545.2 ENST00000394419.4 |
ACTN1 |
actinin, alpha 1 |
chr3_+_110790590 | 5.79 |
ENST00000485303.1 |
PVRL3 |
poliovirus receptor-related 3 |
chrX_+_135229559 | 5.79 |
ENST00000394155.2 |
FHL1 |
four and a half LIM domains 1 |
chr20_-_17662878 | 5.73 |
ENST00000377813.1 ENST00000377807.2 ENST00000360807.4 ENST00000398782.2 |
RRBP1 |
ribosome binding protein 1 |
chr4_+_169753156 | 5.73 |
ENST00000393726.3 ENST00000507735.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr12_-_106641728 | 5.72 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr7_+_94023873 | 5.71 |
ENST00000297268.6 |
COL1A2 |
collagen, type I, alpha 2 |
chr8_+_94929110 | 5.60 |
ENST00000520728.1 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr2_-_216300784 | 5.59 |
ENST00000421182.1 ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1 |
fibronectin 1 |
chr2_-_20212422 | 5.59 |
ENST00000421259.2 ENST00000407540.3 |
MATN3 |
matrilin 3 |
chr14_-_89883412 | 5.57 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr2_-_161349909 | 5.56 |
ENST00000392753.3 |
RBMS1 |
RNA binding motif, single stranded interacting protein 1 |
chr1_-_94703118 | 5.55 |
ENST00000260526.6 ENST00000370217.3 |
ARHGAP29 |
Rho GTPase activating protein 29 |
chr9_-_139940608 | 5.55 |
ENST00000371601.4 |
NPDC1 |
neural proliferation, differentiation and control, 1 |
chr8_+_26371763 | 5.50 |
ENST00000521913.1 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr22_+_38142235 | 5.49 |
ENST00000407319.2 ENST00000403663.2 ENST00000428075.1 |
TRIOBP |
TRIO and F-actin binding protein |
chr20_-_17662705 | 5.48 |
ENST00000455029.2 |
RRBP1 |
ribosome binding protein 1 |
chr14_-_105444694 | 5.46 |
ENST00000333244.5 |
AHNAK2 |
AHNAK nucleoprotein 2 |
chr13_+_98794810 | 5.42 |
ENST00000595437.1 |
FARP1 |
FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) |
chr2_+_110371905 | 5.42 |
ENST00000356454.3 |
SOWAHC |
sosondowah ankyrin repeat domain family member C |
chr14_+_21538429 | 5.38 |
ENST00000298694.4 ENST00000555038.1 |
ARHGEF40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
chr15_-_90358048 | 5.37 |
ENST00000300060.6 ENST00000560137.1 |
ANPEP |
alanyl (membrane) aminopeptidase |
chr14_+_102027688 | 5.36 |
ENST00000510508.4 ENST00000359323.3 |
DIO3 |
deiodinase, iodothyronine, type III |
chr20_-_50384864 | 5.36 |
ENST00000311637.5 ENST00000402822.1 |
ATP9A |
ATPase, class II, type 9A |
chr11_+_12696102 | 5.36 |
ENST00000527636.1 ENST00000527376.1 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr9_+_133320301 | 5.34 |
ENST00000352480.5 |
ASS1 |
argininosuccinate synthase 1 |
chr6_+_31865552 | 5.33 |
ENST00000469372.1 ENST00000497706.1 |
C2 |
complement component 2 |
chr8_-_18871159 | 5.29 |
ENST00000327040.8 ENST00000440756.2 |
PSD3 |
pleckstrin and Sec7 domain containing 3 |
chr9_-_13279589 | 5.29 |
ENST00000319217.7 |
MPDZ |
multiple PDZ domain protein |
chr20_-_23618582 | 5.27 |
ENST00000398411.1 ENST00000376925.3 |
CST3 |
cystatin C |
chr11_-_2158507 | 5.24 |
ENST00000381392.1 ENST00000381395.1 ENST00000418738.2 |
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
chr11_+_101981169 | 5.21 |
ENST00000526343.1 ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1 |
Yes-associated protein 1 |
chr7_-_47621736 | 5.20 |
ENST00000311160.9 |
TNS3 |
tensin 3 |
chr16_+_56691911 | 5.20 |
ENST00000568475.1 |
MT1F |
metallothionein 1F |
chr7_-_45960850 | 5.19 |
ENST00000381083.4 ENST00000381086.5 ENST00000275521.6 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
chr7_+_79764104 | 5.19 |
ENST00000351004.3 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
chr3_+_135684515 | 5.16 |
ENST00000264977.3 ENST00000490467.1 |
PPP2R3A |
protein phosphatase 2, regulatory subunit B'', alpha |
chr21_+_47518011 | 5.12 |
ENST00000300527.4 ENST00000357838.4 ENST00000310645.5 |
COL6A2 |
collagen, type VI, alpha 2 |
chr6_-_138428613 | 5.10 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr1_+_17866290 | 5.09 |
ENST00000361221.3 ENST00000452522.1 ENST00000434513.1 |
ARHGEF10L |
Rho guanine nucleotide exchange factor (GEF) 10-like |
chr9_-_13279563 | 5.09 |
ENST00000541718.1 |
MPDZ |
multiple PDZ domain protein |
chr10_-_62761188 | 5.08 |
ENST00000357917.4 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
chr2_-_175869936 | 5.08 |
ENST00000409900.3 |
CHN1 |
chimerin 1 |
chr14_+_21538517 | 5.07 |
ENST00000298693.3 |
ARHGEF40 |
Rho guanine nucleotide exchange factor (GEF) 40 |
chr16_+_56703737 | 5.05 |
ENST00000569155.1 |
MT1H |
metallothionein 1H |
chr12_-_13153139 | 5.05 |
ENST00000536942.1 ENST00000014930.4 |
HEBP1 |
heme binding protein 1 |
chrX_+_51928002 | 5.00 |
ENST00000375626.3 |
MAGED4 |
melanoma antigen family D, 4 |
chr2_+_46926326 | 4.98 |
ENST00000394861.2 |
SOCS5 |
suppressor of cytokine signaling 5 |
chr22_+_45898712 | 4.98 |
ENST00000455233.1 ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1 |
fibulin 1 |
chr8_+_94929077 | 4.96 |
ENST00000297598.4 ENST00000520614.1 |
PDP1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
chr3_-_114866084 | 4.96 |
ENST00000357258.3 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr10_+_181418 | 4.95 |
ENST00000403354.1 ENST00000381607.4 ENST00000402736.1 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
chr8_+_42995548 | 4.95 |
ENST00000458501.2 ENST00000379644.4 |
HGSNAT |
heparan-alpha-glucosaminide N-acetyltransferase |
chr17_-_1389228 | 4.94 |
ENST00000438665.2 |
MYO1C |
myosin IC |
chr12_+_53491220 | 4.91 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr7_-_107642348 | 4.88 |
ENST00000393561.1 |
LAMB1 |
laminin, beta 1 |
chr10_+_114709999 | 4.88 |
ENST00000355995.4 ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr10_-_17659357 | 4.86 |
ENST00000326961.6 ENST00000361271.3 |
PTPLA |
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr10_-_126847276 | 4.83 |
ENST00000531469.1 |
CTBP2 |
C-terminal binding protein 2 |
chr3_+_23986748 | 4.80 |
ENST00000312521.4 |
NR1D2 |
nuclear receptor subfamily 1, group D, member 2 |
chr3_-_129612394 | 4.79 |
ENST00000505616.1 ENST00000426664.2 |
TMCC1 |
transmembrane and coiled-coil domain family 1 |
chr10_+_180987 | 4.78 |
ENST00000381591.1 |
ZMYND11 |
zinc finger, MYND-type containing 11 |
chr4_-_52904425 | 4.76 |
ENST00000535450.1 |
SGCB |
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
chr16_+_56666563 | 4.74 |
ENST00000570233.1 |
MT1M |
metallothionein 1M |
chr20_-_43977055 | 4.74 |
ENST00000372733.3 ENST00000537976.1 |
SDC4 |
syndecan 4 |
chr5_-_111093406 | 4.71 |
ENST00000379671.3 |
NREP |
neuronal regeneration related protein |
chr11_+_129939811 | 4.70 |
ENST00000345598.5 ENST00000338167.5 |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
chr17_+_80186273 | 4.69 |
ENST00000584689.1 ENST00000392341.1 ENST00000583237.1 |
SLC16A3 |
solute carrier family 16 (monocarboxylate transporter), member 3 |
chr16_+_56691838 | 4.69 |
ENST00000394501.2 |
MT1F |
metallothionein 1F |
chr21_+_35014783 | 4.69 |
ENST00000381291.4 ENST00000381285.4 ENST00000399367.3 ENST00000399352.1 ENST00000399355.2 ENST00000399349.1 |
ITSN1 |
intersectin 1 (SH3 domain protein) |
chr10_-_15413035 | 4.69 |
ENST00000378116.4 ENST00000455654.1 |
FAM171A1 |
family with sequence similarity 171, member A1 |
chr2_+_187454749 | 4.68 |
ENST00000261023.3 ENST00000374907.3 |
ITGAV |
integrin, alpha V |
chr2_+_30369859 | 4.68 |
ENST00000402003.3 |
YPEL5 |
yippee-like 5 (Drosophila) |
chr14_-_74960030 | 4.67 |
ENST00000553490.1 ENST00000557510.1 |
NPC2 |
Niemann-Pick disease, type C2 |
chr9_-_94186131 | 4.67 |
ENST00000297689.3 |
NFIL3 |
nuclear factor, interleukin 3 regulated |
chr2_+_201170770 | 4.66 |
ENST00000409988.3 ENST00000409385.1 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr14_+_105941118 | 4.65 |
ENST00000550577.1 ENST00000538259.2 |
CRIP2 |
cysteine-rich protein 2 |
chr3_+_12329358 | 4.65 |
ENST00000309576.6 |
PPARG |
peroxisome proliferator-activated receptor gamma |
chr6_-_11044509 | 4.64 |
ENST00000354666.3 |
ELOVL2 |
ELOVL fatty acid elongase 2 |
chr10_+_120863587 | 4.64 |
ENST00000535029.1 ENST00000361432.2 ENST00000544016.1 |
FAM45A |
family with sequence similarity 45, member A |
chr6_-_52441713 | 4.63 |
ENST00000182527.3 |
TRAM2 |
translocation associated membrane protein 2 |
chr3_-_55521323 | 4.63 |
ENST00000264634.4 |
WNT5A |
wingless-type MMTV integration site family, member 5A |
chr14_+_105781048 | 4.61 |
ENST00000458164.2 ENST00000447393.1 |
PACS2 |
phosphofurin acidic cluster sorting protein 2 |
chr17_-_66453562 | 4.58 |
ENST00000262139.5 ENST00000546360.1 |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
chrX_-_51239425 | 4.58 |
ENST00000375992.3 |
NUDT11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
chr16_+_56672571 | 4.56 |
ENST00000290705.8 |
MT1A |
metallothionein 1A |
chr19_-_19051993 | 4.51 |
ENST00000594794.1 ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3 |
homer homolog 3 (Drosophila) |
chr13_-_80915059 | 4.50 |
ENST00000377104.3 |
SPRY2 |
sprouty homolog 2 (Drosophila) |
chr9_-_35691017 | 4.48 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr9_+_133320339 | 4.47 |
ENST00000372394.1 ENST00000372393.3 ENST00000422569.1 |
ASS1 |
argininosuccinate synthase 1 |
chr15_+_81071684 | 4.44 |
ENST00000220244.3 ENST00000394685.3 ENST00000356249.5 |
KIAA1199 |
KIAA1199 |
chr2_-_169104651 | 4.42 |
ENST00000355999.4 |
STK39 |
serine threonine kinase 39 |
chr2_-_235405679 | 4.42 |
ENST00000390645.2 |
ARL4C |
ADP-ribosylation factor-like 4C |
chr3_-_134093395 | 4.42 |
ENST00000249883.5 |
AMOTL2 |
angiomotin like 2 |
chr8_+_1711918 | 4.39 |
ENST00000331222.4 |
CLN8 |
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
chr8_+_26435359 | 4.38 |
ENST00000311151.5 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr16_-_65155979 | 4.38 |
ENST00000562325.1 ENST00000268603.4 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr20_+_11871433 | 4.36 |
ENST00000399006.2 ENST00000405977.1 |
BTBD3 |
BTB (POZ) domain containing 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
3.6 | 25.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
3.3 | 9.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
3.1 | 18.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.7 | 13.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
2.5 | 17.6 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
2.3 | 16.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
2.2 | 13.0 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
2.1 | 2.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
2.1 | 10.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
2.0 | 7.8 | GO:0043398 | HLH domain binding(GO:0043398) |
2.0 | 33.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.9 | 1.9 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.9 | 5.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
1.9 | 13.0 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.8 | 20.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.8 | 14.6 | GO:0045159 | myosin II binding(GO:0045159) |
1.8 | 10.8 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.8 | 16.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
1.8 | 23.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.7 | 1.7 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
1.6 | 6.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.6 | 8.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.6 | 4.9 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
1.6 | 8.1 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.6 | 6.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.6 | 11.0 | GO:0016015 | morphogen activity(GO:0016015) |
1.6 | 6.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.5 | 6.2 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
1.5 | 6.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.5 | 56.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.5 | 24.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
1.4 | 7.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.4 | 31.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.3 | 4.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
1.3 | 4.0 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
1.3 | 3.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.3 | 3.9 | GO:0035501 | MH1 domain binding(GO:0035501) |
1.3 | 23.0 | GO:0048185 | activin binding(GO:0048185) |
1.3 | 12.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.3 | 7.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.3 | 6.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.2 | 3.7 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.2 | 3.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 3.6 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
1.2 | 4.8 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
1.2 | 52.5 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 4.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.2 | 7.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
1.2 | 9.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.1 | 26.4 | GO:0017166 | vinculin binding(GO:0017166) |
1.1 | 3.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.1 | 5.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.1 | 3.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
1.1 | 3.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
1.1 | 27.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.1 | 11.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.1 | 5.5 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
1.1 | 3.2 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
1.0 | 5.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
1.0 | 4.1 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
1.0 | 18.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
1.0 | 3.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
1.0 | 4.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.0 | 1.0 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 3.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.0 | 3.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.0 | 8.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
1.0 | 5.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 8.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 23.9 | GO:0043394 | proteoglycan binding(GO:0043394) |
1.0 | 22.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 1.0 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.9 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.9 | 9.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.9 | 4.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.9 | 5.5 | GO:0039552 | RIG-I binding(GO:0039552) |
0.9 | 2.7 | GO:0030984 | kininogen binding(GO:0030984) |
0.9 | 4.5 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.9 | 2.7 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.9 | 13.9 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.9 | 40.9 | GO:0030546 | receptor activator activity(GO:0030546) |
0.9 | 6.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 6.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.9 | 2.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.8 | 4.2 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 10.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.8 | 3.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.8 | 2.5 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.8 | 3.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.8 | 3.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 3.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 4.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.8 | 3.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.8 | 28.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 0.8 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.8 | 2.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.8 | 2.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.8 | 3.9 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.8 | 3.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.8 | 7.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.8 | 21.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 4.5 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.7 | 2.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.7 | 5.8 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.7 | 4.3 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.7 | 3.6 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.7 | 2.9 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.7 | 2.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.7 | 8.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 7.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.7 | 10.6 | GO:0043236 | laminin binding(GO:0043236) |
0.7 | 2.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.7 | 2.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.7 | 2.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 6.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 15.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 3.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.7 | 3.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 55.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.7 | 9.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 3.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 6.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.7 | 3.3 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.7 | 8.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.6 | 2.6 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.6 | 0.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.6 | 0.6 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 5.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.6 | 1.3 | GO:0097001 | ceramide binding(GO:0097001) |
0.6 | 15.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 2.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 6.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.6 | 1.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.6 | 5.5 | GO:0001968 | fibronectin binding(GO:0001968) |
0.6 | 2.4 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.6 | 50.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.6 | 12.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 1.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.6 | 1.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.6 | 3.5 | GO:0046979 | TAP2 binding(GO:0046979) |
0.6 | 4.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 1.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.6 | 15.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 1.7 | GO:0070984 | SET domain binding(GO:0070984) |
0.6 | 3.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.6 | 0.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.6 | 0.6 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.6 | 2.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.5 | 6.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.5 | 1.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 2.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.5 | 2.2 | GO:0004803 | transposase activity(GO:0004803) |
0.5 | 2.2 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.5 | 1.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 1.6 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 11.7 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.5 | 11.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.5 | 1.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.5 | 0.5 | GO:0070697 | activin receptor binding(GO:0070697) type II activin receptor binding(GO:0070699) |
0.5 | 7.9 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 0.5 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.5 | 5.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 0.5 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.5 | 2.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.5 | 2.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.5 | 1.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.5 | 2.0 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.5 | 2.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.5 | 7.1 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.5 | 1.5 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 1.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.5 | 3.5 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 2.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.5 | 2.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.5 | 1.5 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.5 | 2.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.5 | 3.5 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.5 | 7.9 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 3.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.5 | 2.0 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.5 | 1.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 1.4 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 1.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.5 | 2.4 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 2.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.5 | 2.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.5 | 1.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.5 | 1.4 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
0.5 | 0.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 3.7 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.5 | 2.8 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.5 | 1.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.4 | 1.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.4 | 3.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.4 | 44.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.4 | 1.3 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 1.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.4 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.4 | 3.9 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.4 | 20.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.4 | 4.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.4 | 3.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 2.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.4 | 5.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.4 | 15.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.4 | 7.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.4 | 0.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.4 | 10.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.4 | 6.8 | GO:0019841 | retinol binding(GO:0019841) |
0.4 | 0.4 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.4 | 1.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.2 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
0.4 | 2.5 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.4 | 1.6 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.4 | 1.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 2.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 2.4 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.4 | 2.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.4 | 1.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 47.7 | GO:0005178 | integrin binding(GO:0005178) |
0.4 | 2.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 6.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 2.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 3.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.4 | 5.8 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.4 | 8.5 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.5 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.4 | 8.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 4.2 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 1.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.4 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
0.4 | 5.9 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.5 | GO:0047708 | biotinidase activity(GO:0047708) |
0.4 | 26.9 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 5.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.4 | 2.9 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.4 | 8.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.4 | 3.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.4 | 1.1 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
0.4 | 4.0 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.4 | 3.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 0.7 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 4.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.4 | 3.9 | GO:0039706 | co-receptor binding(GO:0039706) |
0.4 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 1.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.4 | 2.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.3 | 2.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 20.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 0.7 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 7.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 12.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 2.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.3 | 3.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.3 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.3 | 1.7 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.3 | 1.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 5.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 5.3 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 6.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.3 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 2.0 | GO:0017022 | myosin binding(GO:0017022) |
0.3 | 5.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.3 | 23.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 1.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.6 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.3 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 1.0 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 10.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 2.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.9 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.3 | 2.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 1.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 1.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.3 | 4.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 1.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 7.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.3 | 6.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.3 | 1.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 9.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 0.9 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.3 | 8.3 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.3 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.3 | 0.9 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.3 | 4.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.3 | 0.9 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.3 | 2.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.3 | 7.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 8.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 0.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 0.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.3 | 1.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.3 | 1.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 7.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 0.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.3 | 1.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.3 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.3 | 0.8 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.3 | 0.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.3 | 7.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 0.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.3 | 0.3 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 3.4 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 0.8 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.3 | 12.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 0.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.3 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.3 | 1.0 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 3.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 1.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 1.0 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.2 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.2 | 2.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.2 | 7.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 7.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 0.5 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.2 | 3.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.7 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.2 | 0.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 1.6 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 0.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.7 | GO:0016297 | oleoyl-[acyl-carrier-protein] hydrolase activity(GO:0004320) myristoyl-[acyl-carrier-protein] hydrolase activity(GO:0016295) palmitoyl-[acyl-carrier-protein] hydrolase activity(GO:0016296) acyl-[acyl-carrier-protein] hydrolase activity(GO:0016297) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 5.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.2 | 1.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.2 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 33.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 0.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 4.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 0.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.5 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 2.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 2.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 1.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 0.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 2.2 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
0.2 | 1.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 5.7 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 2.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 0.6 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 1.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 3.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 0.6 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.2 | 4.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 0.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.6 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 1.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 0.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.2 | 3.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 0.7 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.2 | 0.5 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
0.2 | 0.4 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 4.2 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.2 | 0.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.8 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 4.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 1.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 0.4 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 7.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.2 | 19.0 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 1.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 1.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.2 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.2 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.2 | 1.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 3.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 0.2 | GO:0032810 | sterol response element binding(GO:0032810) |
0.2 | 1.5 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.2 | 2.3 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 5.7 | GO:0050699 | WW domain binding(GO:0050699) |
0.2 | 5.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.2 | 2.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.2 | 0.8 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 31.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 1.0 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.5 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
0.2 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 1.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.2 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 0.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 0.5 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.2 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 2.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.6 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
0.1 | 1.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 3.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 3.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.6 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 1.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 3.7 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.5 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 1.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 2.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 2.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.4 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.5 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.2 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.1 | 0.6 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 41.3 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 0.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 1.1 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 3.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 2.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 1.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.8 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.1 | 0.2 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 3.8 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 0.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.6 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 1.3 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 2.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 0.4 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 0.3 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.1 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 8.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.6 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 2.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 2.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.3 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.3 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 13.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.5 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 2.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 1.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 2.1 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 2.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 2.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.7 | GO:0035877 | death effector domain binding(GO:0035877) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 2.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 1.1 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 1.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.7 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 3.4 | GO:0019838 | growth factor binding(GO:0019838) |
0.1 | 0.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.3 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.1 | 0.2 | GO:0035671 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 5.0 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 0.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 2.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 1.2 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.7 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 14.3 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.7 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.1 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.2 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.1 | 26.1 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 1.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 1.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 3.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.1 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
0.1 | 4.4 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.1 | 1.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.1 | 0.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.2 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.3 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 1.4 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.0 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.0 | 0.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.3 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 0.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 1.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.0 | 0.2 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 0.1 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.0 | 0.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.0 | 0.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.4 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 3.1 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.0 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 2.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.4 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.2 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.0 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.0 | 0.6 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.9 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.0 | 0.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.0 | 0.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 46.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.6 | 41.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.5 | 27.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
1.4 | 71.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.3 | 25.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.2 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.0 | 19.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.0 | 17.0 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.0 | 23.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 36.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.9 | 3.7 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.9 | 0.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.9 | 0.9 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 12.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.9 | 24.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 16.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.8 | 52.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.8 | 11.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.8 | 2.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.8 | 7.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 17.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.8 | 18.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.7 | 4.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.7 | 15.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 8.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 43.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.7 | 15.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.6 | 6.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.6 | 19.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.6 | 13.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 17.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 6.0 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 6.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 9.7 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.5 | 14.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.5 | 14.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 9.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.5 | 8.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.5 | 0.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.4 | 4.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.4 | 0.9 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 8.5 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.4 | 6.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.4 | 5.9 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 6.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.4 | 1.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.4 | 1.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 4.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 12.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 4.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 10.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 8.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.3 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 13.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.3 | 4.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 7.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 42.9 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.3 | 5.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 5.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.3 | 17.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.3 | 9.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.3 | 8.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 31.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 25.9 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.3 | 3.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.3 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 2.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 4.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 5.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.2 | 19.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 5.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 10.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 5.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 1.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 4.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 1.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.2 | 3.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 3.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 1.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 6.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 2.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.2 | 1.0 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 9.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 0.9 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 10.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 5.4 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.2 | 1.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.2 | 4.5 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.2 | 2.4 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 3.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 2.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.9 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 2.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 2.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 5.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 5.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 4.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 7.8 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 1.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 2.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 8.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 1.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 7.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.1 | 3.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 0.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 2.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.8 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 2.5 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.9 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 2.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 8.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 0.6 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 1.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.6 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 4.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.4 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.9 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 6.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 2.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 3.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 1.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 2.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 28.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
1.1 | 59.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.0 | 18.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 43.6 | NABA COLLAGENS | Genes encoding collagen proteins |
0.9 | 24.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.8 | 37.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.8 | 21.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.8 | 57.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 42.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.7 | 4.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 1.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.6 | 10.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 24.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 23.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 126.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.6 | 19.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 43.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 34.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.5 | 19.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.5 | 22.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.5 | 9.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 8.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 1.7 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 14.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 10.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.4 | 14.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.4 | 3.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 94.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 9.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 13.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 2.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 14.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 23.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.3 | 5.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 19.0 | PID BMP PATHWAY | BMP receptor signaling |
0.3 | 5.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.3 | 3.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 2.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.3 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 5.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 9.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 16.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 8.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.3 | 3.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 43.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 8.5 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 3.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 9.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 12.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.2 | 3.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.2 | 3.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 3.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 5.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.2 | 12.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 2.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 6.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 2.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 1.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.1 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 3.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 9.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 9.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 3.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 4.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 4.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 2.9 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 24.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 1.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.6 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 1.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 17.4 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
4.9 | 19.6 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
4.7 | 23.3 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
4.4 | 4.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) metanephric part of ureteric bud development(GO:0035502) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
3.8 | 11.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
3.6 | 3.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
3.3 | 39.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
3.2 | 19.1 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
3.2 | 12.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
3.0 | 12.0 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
3.0 | 20.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
2.8 | 8.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
2.8 | 25.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
2.7 | 10.7 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
2.6 | 23.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.5 | 10.2 | GO:1902730 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
2.4 | 7.3 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.4 | 9.5 | GO:0021564 | vagus nerve development(GO:0021564) |
2.4 | 4.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
2.4 | 61.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
2.3 | 7.0 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
2.3 | 11.6 | GO:0030047 | actin modification(GO:0030047) |
2.3 | 11.6 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
2.3 | 4.6 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
2.2 | 2.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.2 | 8.8 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
2.2 | 15.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
2.2 | 17.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.2 | 6.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.2 | 8.6 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
2.1 | 12.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.1 | 10.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
2.1 | 23.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
2.1 | 2.1 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
2.1 | 8.3 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
2.0 | 20.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.0 | 5.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
2.0 | 15.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
1.9 | 5.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.9 | 3.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.9 | 7.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.9 | 20.6 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
1.9 | 3.8 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) regulation of negative chemotaxis(GO:0050923) |
1.9 | 9.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.8 | 12.8 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.8 | 3.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
1.8 | 8.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
1.8 | 5.3 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.7 | 5.2 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.7 | 5.2 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
1.7 | 27.4 | GO:0051639 | actin filament network formation(GO:0051639) |
1.7 | 6.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.7 | 6.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
1.7 | 6.7 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
1.7 | 10.0 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
1.6 | 1.6 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
1.6 | 3.2 | GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
1.6 | 6.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
1.6 | 17.4 | GO:0034465 | response to carbon monoxide(GO:0034465) |
1.6 | 1.6 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.6 | 4.7 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
1.6 | 7.8 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
1.5 | 1.5 | GO:0010159 | specification of organ position(GO:0010159) |
1.5 | 4.6 | GO:2000521 | negative regulation of immunological synapse formation(GO:2000521) |
1.5 | 4.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
1.5 | 15.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
1.5 | 4.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.5 | 4.5 | GO:0090427 | activation of meiosis(GO:0090427) |
1.5 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
1.5 | 4.5 | GO:0060437 | lung growth(GO:0060437) |
1.5 | 1.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
1.5 | 6.0 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
1.5 | 4.4 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
1.5 | 7.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
1.5 | 1.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.5 | 4.4 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 8.7 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.5 | 4.4 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
1.4 | 4.3 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.4 | 1.4 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
1.4 | 4.3 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.4 | 1.4 | GO:0035989 | tendon development(GO:0035989) |
1.4 | 5.5 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
1.4 | 5.5 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.4 | 13.7 | GO:0070141 | response to UV-A(GO:0070141) |
1.4 | 4.1 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
1.4 | 14.9 | GO:0009414 | response to water deprivation(GO:0009414) |
1.3 | 1.3 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
1.3 | 6.6 | GO:0018158 | protein oxidation(GO:0018158) |
1.3 | 6.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
1.3 | 4.0 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
1.3 | 3.9 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
1.3 | 11.7 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
1.3 | 9.0 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.3 | 5.1 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
1.3 | 6.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.3 | 8.8 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.3 | 10.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.2 | 5.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.2 | 8.7 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.2 | 3.7 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
1.2 | 8.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.2 | 8.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.2 | 12.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
1.2 | 6.1 | GO:0030035 | microspike assembly(GO:0030035) |
1.2 | 4.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
1.2 | 18.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.2 | 4.8 | GO:0046108 | uridine catabolic process(GO:0006218) uridine metabolic process(GO:0046108) |
1.2 | 4.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 3.6 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
1.2 | 1.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.2 | 5.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.2 | 3.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.2 | 5.8 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) |
1.2 | 1.2 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
1.1 | 6.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
1.1 | 8.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
1.1 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.1 | 4.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
1.1 | 1.1 | GO:1903521 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.1 | 9.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.1 | 2.3 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
1.1 | 32.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 3.4 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.1 | 4.4 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
1.1 | 3.3 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
1.1 | 4.4 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.1 | 7.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.1 | 2.2 | GO:1900046 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
1.1 | 3.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
1.1 | 17.2 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.1 | 5.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
1.1 | 4.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
1.1 | 1.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.1 | 3.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.1 | 2.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
1.0 | 3.1 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.0 | 5.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.0 | 2.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.0 | 6.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.0 | 6.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.0 | 3.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 9.0 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.0 | 4.0 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
1.0 | 19.7 | GO:0046697 | decidualization(GO:0046697) |
1.0 | 1.0 | GO:0007032 | endosome organization(GO:0007032) |
1.0 | 1.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.0 | 2.9 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
1.0 | 15.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.0 | 2.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
1.0 | 11.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
1.0 | 1.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
1.0 | 5.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.9 | 0.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.9 | 7.5 | GO:0046618 | drug export(GO:0046618) |
0.9 | 2.8 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.9 | 2.8 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.9 | 5.6 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.9 | 2.8 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.9 | 3.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.9 | 7.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.9 | 3.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 1.8 | GO:0097475 | motor neuron migration(GO:0097475) |
0.9 | 0.9 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.9 | 1.8 | GO:2000542 | negative regulation of cell fate specification(GO:0009996) negative regulation of gastrulation(GO:2000542) |
0.9 | 1.8 | GO:0000050 | urea cycle(GO:0000050) |
0.9 | 2.7 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.9 | 4.5 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.9 | 0.9 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.9 | 3.6 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.9 | 2.7 | GO:0014028 | notochord formation(GO:0014028) |
0.9 | 1.8 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.9 | 12.2 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.9 | 3.5 | GO:0072144 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.9 | 5.2 | GO:0070836 | caveola assembly(GO:0070836) |
0.9 | 4.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.9 | 7.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.9 | 21.5 | GO:0033622 | integrin activation(GO:0033622) |
0.9 | 2.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.9 | 1.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.9 | 3.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.8 | 7.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.8 | 3.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.8 | 2.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.8 | 2.5 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.8 | 4.1 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.8 | 8.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.8 | 2.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.8 | 2.5 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.8 | 5.7 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 6.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.8 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
0.8 | 2.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.8 | 3.2 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.8 | 2.4 | GO:0009183 | purine deoxyribonucleotide biosynthetic process(GO:0009153) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.8 | 7.2 | GO:2000647 | negative regulation of stem cell proliferation(GO:2000647) |
0.8 | 2.4 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.8 | 0.8 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.8 | 2.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.8 | 0.8 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.8 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.8 | 2.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.8 | 16.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.8 | 14.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.8 | 4.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.8 | 9.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.8 | 3.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.8 | 1.5 | GO:1901213 | regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901213) |
0.8 | 3.8 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.8 | 6.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.8 | 7.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 6.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.8 | 6.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.8 | 6.8 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.8 | 3.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.8 | 3.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.7 | 3.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.7 | 5.2 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.7 | 4.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.7 | 7.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 3.7 | GO:0010269 | response to selenium ion(GO:0010269) |
0.7 | 10.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.7 | 2.2 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.7 | 31.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.7 | 13.3 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.7 | 2.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 2.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.7 | 4.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.7 | 2.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.7 | 2.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.7 | 2.9 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 2.9 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.7 | 2.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.7 | 2.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.7 | 1.4 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 4.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.7 | 12.8 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
0.7 | 1.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.7 | 2.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.7 | 7.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.7 | 1.4 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.7 | 3.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.7 | 25.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.7 | 1.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.7 | 11.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.7 | 3.4 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.7 | 2.0 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.7 | 8.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.7 | 2.7 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.7 | 0.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.7 | 6.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.7 | 5.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.7 | 6.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 2.0 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.7 | 1.3 | GO:0003285 | septum secundum development(GO:0003285) |
0.7 | 0.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.7 | 13.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.6 | 2.6 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 1.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.6 | 0.6 | GO:0006907 | pinocytosis(GO:0006907) |
0.6 | 1.9 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.6 | 3.8 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.6 | 1.9 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.6 | 9.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.6 | 0.6 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.6 | 2.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.6 | 2.5 | GO:0048749 | compound eye development(GO:0048749) |
0.6 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.6 | 2.5 | GO:0002086 | maltose metabolic process(GO:0000023) diaphragm contraction(GO:0002086) |
0.6 | 3.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 14.2 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.6 | 4.9 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.6 | 4.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.6 | 8.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.6 | 1.2 | GO:2000910 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
0.6 | 3.0 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.6 | 0.6 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.6 | 2.4 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.6 | 0.6 | GO:0031345 | negative regulation of cell projection organization(GO:0031345) |
0.6 | 19.3 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.6 | 9.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 1.8 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.6 | 4.8 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 1.8 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.6 | 5.3 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.6 | 4.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.6 | 1.2 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.6 | 4.0 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.6 | 1.7 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.6 | 0.6 | GO:0003306 | Wnt signaling pathway involved in heart development(GO:0003306) |
0.6 | 8.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.6 | 3.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.6 | 0.6 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.6 | 2.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.6 | 0.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.6 | 1.7 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.6 | 3.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.6 | 1.7 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) positive regulation of phospholipid catabolic process(GO:0060697) |
0.6 | 1.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.6 | 0.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.6 | 0.6 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.6 | 2.8 | GO:0051414 | response to cortisol(GO:0051414) |
0.5 | 3.3 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 1.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 2.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.5 | 7.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.5 | 2.2 | GO:1903412 | response to bile acid(GO:1903412) |
0.5 | 1.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.5 | 2.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.5 | 3.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 7.9 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.5 | 1.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.5 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.5 | 1.6 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) forelimb morphogenesis(GO:0035136) |
0.5 | 4.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 3.1 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.5 | 6.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.5 | 0.5 | GO:0048675 | axon extension(GO:0048675) |
0.5 | 3.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.5 | 1.5 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 | 6.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 5.1 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 1.5 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.5 | 1.5 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.5 | 2.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 1.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.5 | 1.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.5 | 1.0 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.5 | 6.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.5 | 1.5 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 2.0 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.5 | 2.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.5 | 0.5 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.5 | 3.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.5 | 1.5 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.5 | 4.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.5 | 1.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.5 | 1.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.5 | 1.0 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.5 | 3.4 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
0.5 | 4.8 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.5 | 2.9 | GO:0032328 | alanine transport(GO:0032328) |
0.5 | 1.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.5 | 2.9 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.5 | 0.5 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.5 | 1.9 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.5 | 15.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 4.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.5 | 2.4 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.5 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.5 | 1.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.5 | 1.9 | GO:0061290 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.5 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.5 | 2.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.5 | 1.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 9.3 | GO:0071711 | basement membrane organization(GO:0071711) |
0.5 | 1.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.5 | 3.2 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.5 | 1.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.5 | 0.9 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.5 | 1.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.5 | 1.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 4.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.5 | 1.8 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.5 | 3.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 2.7 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.5 | 1.4 | GO:1902617 | response to fluoride(GO:1902617) |
0.4 | 1.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.4 | 19.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.4 | 0.4 | GO:0030104 | water homeostasis(GO:0030104) |
0.4 | 2.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.4 | 5.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.4 | 0.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 5.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 0.9 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.4 | 0.9 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
0.4 | 1.7 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.4 | 3.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 0.4 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.4 | 0.9 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 4.3 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 9.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.3 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
0.4 | 3.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.4 | 4.3 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.4 | 1.3 | GO:0034063 | stress granule assembly(GO:0034063) |
0.4 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 2.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 0.8 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.4 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.4 | 2.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.4 | 1.3 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 1.6 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
0.4 | 1.6 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.4 | 2.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.4 | 1.2 | GO:0097056 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
0.4 | 0.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.4 | 1.6 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.4 | 2.0 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.4 | 1.6 | GO:0046836 | glycolipid transport(GO:0046836) |
0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.6 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
0.4 | 1.2 | GO:0071529 | cementum mineralization(GO:0071529) |
0.4 | 0.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.4 | 1.2 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.4 | 1.6 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.4 | 5.6 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 2.8 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 1.2 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 3.1 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.4 | 0.8 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 2.3 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.4 | 8.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.4 | 1.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 1.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 2.7 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 0.8 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.4 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 1.2 | GO:0035878 | nail development(GO:0035878) |
0.4 | 1.9 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.4 | 0.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.4 | 4.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 3.4 | GO:0009629 | response to gravity(GO:0009629) |
0.4 | 0.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 1.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 1.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 4.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 1.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 4.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 1.1 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 5.2 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 0.4 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.4 | 4.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.4 | 0.7 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.4 | 2.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.4 | 3.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.4 | 1.1 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.4 | 5.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.4 | 4.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 5.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.4 | 6.5 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) |
0.4 | 2.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.4 | 1.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 3.2 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.4 | 3.5 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.4 | 1.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.4 | 1.1 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.4 | 1.8 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.4 | 8.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 1.4 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.3 | 0.3 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.3 | 1.0 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.3 | 1.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.3 | 15.2 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.3 | 0.7 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 3.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.3 | 1.0 | GO:0021886 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
0.3 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 1.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.3 | 1.4 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 0.3 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.3 | 1.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 2.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 1.7 | GO:0060413 | atrial septum morphogenesis(GO:0060413) |
0.3 | 2.0 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.3 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 2.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.3 | 2.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.3 | 0.3 | GO:0060602 | branch elongation of an epithelium(GO:0060602) |
0.3 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.3 | 4.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.3 | 0.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 7.2 | GO:0097178 | ruffle assembly(GO:0097178) |
0.3 | 3.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 2.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.3 | 1.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 5.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.3 | 3.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 2.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.3 | GO:0033604 | negative regulation of catecholamine secretion(GO:0033604) |
0.3 | 1.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.3 | 1.3 | GO:0019046 | release from viral latency(GO:0019046) |
0.3 | 0.6 | GO:0034214 | protein hexamerization(GO:0034214) |
0.3 | 2.8 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 2.2 | GO:1901881 | positive regulation of protein depolymerization(GO:1901881) |
0.3 | 0.6 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 3.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 3.4 | GO:0032456 | endocytic recycling(GO:0032456) |
0.3 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.3 | 1.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.3 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 2.7 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.3 | 0.9 | GO:0071695 | anatomical structure maturation(GO:0071695) |
0.3 | 2.1 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.3 | 1.8 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.3 | 1.2 | GO:0044804 | nucleophagy(GO:0044804) |
0.3 | 0.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.3 | 0.6 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.3 | 0.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 0.3 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.3 | 0.6 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.3 | 0.9 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.3 | 1.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 2.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.3 | 11.2 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.3 | 1.2 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.3 | 1.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.3 | 0.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.3 | 1.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.3 | 0.6 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.3 | 0.3 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.3 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 0.9 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.3 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.3 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.3 | 2.0 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.3 | 0.8 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 3.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 2.0 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 1.1 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 3.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.3 | 1.9 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.3 | 0.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 2.8 | GO:1901621 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 4.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 0.3 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.3 | 0.3 | GO:0032898 | neurotrophin production(GO:0032898) |
0.3 | 1.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 3.5 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.3 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.3 | 1.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.3 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.3 | 0.5 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.3 | 16.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 0.8 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.3 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.3 | 0.3 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.3 | 0.8 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.3 | 0.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 2.1 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.3 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 4.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 0.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 0.8 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.3 | 0.8 | GO:0007172 | signal complex assembly(GO:0007172) |
0.3 | 0.8 | GO:0051412 | response to corticosterone(GO:0051412) |
0.3 | 2.6 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 0.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 | 0.5 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.3 | 14.3 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.8 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.3 | 0.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.3 | 0.8 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.3 | 2.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.3 | 0.8 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.8 | GO:0001881 | receptor recycling(GO:0001881) |
0.3 | 2.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.3 | 13.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 1.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.3 | 2.3 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
0.3 | 0.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.3 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.3 | 2.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 4.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.5 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 2.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.2 | 0.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.2 | 0.2 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
0.2 | 1.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.2 | 0.2 | GO:0060920 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.2 | 1.7 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.2 | 1.7 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.2 | 1.7 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.2 | 1.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.2 | 1.7 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 2.9 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
0.2 | 1.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.5 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.2 | 2.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.2 | 2.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 2.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.2 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.2 | 0.2 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.9 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.2 | 0.5 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.2 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.2 | 3.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.2 | 4.2 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.2 | 2.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.2 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.2 | 0.7 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 1.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 12.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 0.5 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 2.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 1.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.2 | 1.6 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 0.7 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) positive regulation of autophagosome maturation(GO:1901098) |
0.2 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.2 | 1.6 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 0.7 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.2 | 0.5 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.7 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.2 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 0.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.2 | 0.4 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.2 | 1.1 | GO:0003420 | growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 1.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.2 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 4.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.2 | 0.2 | GO:0043578 | nuclear matrix organization(GO:0043578) |
0.2 | 0.9 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 8.4 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.2 | 0.4 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.2 | 0.4 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 0.7 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 11.6 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.7 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.2 | 0.2 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.6 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.2 | 1.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 1.9 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 5.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 2.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.2 | 0.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 3.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 0.4 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.2 | 1.2 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.2 | 0.4 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.2 | 0.6 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.2 | 0.8 | GO:0042335 | cuticle development(GO:0042335) |
0.2 | 1.4 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.2 | 0.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.2 | 1.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 2.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.2 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.2 | 2.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.2 | 0.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.2 | 1.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 0.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 1.0 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.2 | 1.4 | GO:0071709 | membrane assembly(GO:0071709) |
0.2 | 0.4 | GO:1904434 | regulation of T cell antigen processing and presentation(GO:0002625) regulation of iron ion transport(GO:0034756) positive regulation of iron ion transport(GO:0034758) regulation of iron ion transmembrane transport(GO:0034759) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) response to iron ion starvation(GO:1990641) |
0.2 | 4.0 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.2 | 2.6 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 5.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.6 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.6 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.2 | 0.6 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.6 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.2 | 0.6 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.2 | 0.6 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.2 | 0.6 | GO:0014735 | regulation of muscle atrophy(GO:0014735) negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.2 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.2 | 1.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 2.5 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.2 | 1.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 3.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.2 | 1.1 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.2 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.2 | 0.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 0.9 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.6 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.2 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 2.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.5 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
0.2 | 1.8 | GO:0030323 | respiratory tube development(GO:0030323) |
0.2 | 0.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 10.0 | GO:0046323 | glucose import(GO:0046323) |
0.2 | 0.2 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.2 | 1.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.2 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.2 | 1.9 | GO:0007567 | parturition(GO:0007567) |
0.2 | 0.5 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.2 | 0.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 3.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 1.2 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.2 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
0.2 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.2 | 0.5 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.2 | 0.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.2 | 2.7 | GO:0019076 | viral release from host cell(GO:0019076) |
0.2 | 2.9 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 1.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 2.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 0.2 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
0.2 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.2 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.2 | 0.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.2 | 1.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 1.0 | GO:0002911 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.2 | 0.3 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.2 | 1.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 2.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.2 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 0.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.6 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.2 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 1.4 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.6 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.2 | 0.3 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.2 | 1.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.2 | 1.4 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.9 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.2 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.3 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 4.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 2.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.9 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.2 | 2.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.3 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.2 | GO:0035723 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
0.2 | 0.5 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 1.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 2.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.1 | 0.6 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.4 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.1 | 0.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.7 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.1 | 0.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.1 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.6 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 1.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 1.0 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 0.9 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 3.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.9 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.1 | 1.4 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.1 | 0.1 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 5.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.7 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.6 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 29.5 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.1 | 0.8 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.1 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.1 | 1.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.1 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.3 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
0.1 | 0.4 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.1 | 0.5 | GO:0046502 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.5 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 2.1 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 1.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 2.4 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:1904046 | protein localization to nuclear pore(GO:0090204) negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 1.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.1 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.5 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.1 | 1.0 | GO:0071625 | vocalization behavior(GO:0071625) |
0.1 | 1.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.6 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 1.0 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.9 | GO:0042426 | choline catabolic process(GO:0042426) |
0.1 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.7 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 1.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 2.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
0.1 | 7.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.5 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 1.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.1 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 17.0 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 0.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.1 | 0.9 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 2.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.1 | 1.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.1 | GO:0044788 | modulation by host of viral process(GO:0044788) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.8 | GO:0007530 | sex determination(GO:0007530) |
0.1 | 3.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 1.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 0.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 1.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.3 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.1 | 0.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.8 | GO:0030539 | male genitalia development(GO:0030539) |
0.1 | 0.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.1 | GO:0031128 | developmental induction(GO:0031128) |
0.1 | 0.9 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 2.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.1 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 6.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.2 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.3 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
0.1 | 3.9 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.6 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 2.2 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0033216 | copper ion import(GO:0015677) ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.4 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.1 | 1.0 | GO:0006818 | hydrogen transport(GO:0006818) proton transport(GO:0015992) |
0.1 | 0.3 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.1 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.1 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 1.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.6 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.1 | 0.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.5 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.1 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.1 | 0.1 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 2.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.3 | GO:0042509 | regulation of tyrosine phosphorylation of STAT protein(GO:0042509) positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.1 | 0.2 | GO:0070633 | transepithelial transport(GO:0070633) transepithelial ammonium transport(GO:0070634) |
0.1 | 1.8 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.5 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 1.9 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.1 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 1.3 | GO:0097502 | mannosylation(GO:0097502) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.1 | 0.9 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.8 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 0.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.1 | 4.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 1.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.1 | 0.7 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.2 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
0.1 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.6 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.5 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
0.1 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.1 | 1.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 1.3 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.1 | 0.4 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.6 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 5.6 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.3 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 3.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.5 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.9 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.2 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 0.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 1.5 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.6 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.9 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.2 | GO:0072109 | glomerular mesangium development(GO:0072109) |
0.1 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.1 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
0.1 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 1.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.1 | 0.4 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.1 | GO:0021783 | preganglionic parasympathetic fiber development(GO:0021783) |
0.1 | 0.3 | GO:0045188 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.1 | 0.1 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.1 | 0.2 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.7 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.1 | 0.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.2 | GO:0048710 | regulation of astrocyte differentiation(GO:0048710) |
0.1 | 0.1 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.7 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.4 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) |
0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 1.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 1.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.1 | GO:0031641 | regulation of myelination(GO:0031641) |
0.1 | 0.3 | GO:0003094 | glomerular filtration(GO:0003094) |
0.1 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.2 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.1 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.1 | 0.1 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
0.1 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.3 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.4 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.1 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.1 | 0.2 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.1 | 0.1 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.1 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.7 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.0 | 0.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.0 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.2 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.0 | 0.1 | GO:0014866 | skeletal myofibril assembly(GO:0014866) mesenchyme migration(GO:0090131) |
0.0 | 0.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.4 | GO:0060004 | reflex(GO:0060004) |
0.0 | 0.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.5 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway(GO:0038094) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.0 | 0.3 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.2 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 2.4 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.0 | 0.3 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.0 | GO:0060384 | innervation(GO:0060384) |
0.0 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.0 | 1.1 | GO:0015918 | sterol transport(GO:0015918) |
0.0 | 0.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.3 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.3 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.1 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.0 | 0.1 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.1 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 5.0 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.2 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.0 | 0.2 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.0 | 0.9 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.0 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
0.0 | 0.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.0 | 0.1 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.3 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 1.7 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.2 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.2 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.0 | 0.3 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.3 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.2 | GO:0030449 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
0.0 | 0.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.1 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.4 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.5 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 0.1 | GO:0010044 | response to aluminum ion(GO:0010044) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 0.5 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.0 | 0.2 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 0.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.0 | 0.4 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.0 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.0 | 0.0 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.0 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.2 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.0 | 1.6 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.0 | GO:0002276 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
0.0 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.0 | GO:0046732 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.1 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.0 | 0.1 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.0 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.0 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.0 | 0.1 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.6 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.0 | 0.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.0 | 0.0 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.0 | 0.0 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.0 | 0.5 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.1 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.0 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.0 | 0.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 0.0 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.0 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.0 | 1.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) negative regulation of fatty acid metabolic process(GO:0045922) |
0.0 | 0.0 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.1 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.0 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.0 | 0.0 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:1990637 | response to prolactin(GO:1990637) |
0.0 | 0.1 | GO:0014909 | smooth muscle cell migration(GO:0014909) |
0.0 | 0.0 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 19.5 | GO:0043259 | laminin-10 complex(GO:0043259) |
3.8 | 11.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
3.0 | 12.1 | GO:0045160 | myosin I complex(GO:0045160) |
3.0 | 9.1 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
2.9 | 14.3 | GO:0032449 | CBM complex(GO:0032449) |
2.7 | 41.2 | GO:0005916 | fascia adherens(GO:0005916) |
2.7 | 13.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
2.5 | 10.2 | GO:0071664 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
2.3 | 6.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
2.1 | 10.5 | GO:0071797 | LUBAC complex(GO:0071797) |
2.0 | 16.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
1.9 | 9.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.9 | 24.7 | GO:0097470 | ribbon synapse(GO:0097470) |
1.9 | 20.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.6 | 11.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
1.6 | 4.7 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
1.6 | 29.7 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
1.5 | 9.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.4 | 8.5 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
1.4 | 15.1 | GO:0097443 | sorting endosome(GO:0097443) |
1.4 | 5.5 | GO:0031673 | H zone(GO:0031673) |
1.3 | 3.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.2 | 1.2 | GO:0005683 | U7 snRNP(GO:0005683) |
1.2 | 4.8 | GO:0070695 | FHF complex(GO:0070695) |
1.2 | 10.6 | GO:0005955 | calcineurin complex(GO:0005955) |
1.2 | 3.5 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
1.1 | 6.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.1 | 1.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.1 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
1.0 | 5.2 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 10.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.0 | 3.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.0 | 9.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.0 | 3.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 4.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.0 | 14.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.0 | 9.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 13.5 | GO:0031209 | SCAR complex(GO:0031209) |
1.0 | 1.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
1.0 | 19.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.0 | 8.6 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.9 | 10.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 4.5 | GO:1990393 | 3M complex(GO:1990393) |
0.9 | 27.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.9 | 4.4 | GO:0032420 | stereocilium(GO:0032420) |
0.9 | 5.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.8 | 3.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 2.5 | GO:1903349 | omegasome membrane(GO:1903349) |
0.8 | 9.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.8 | 6.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.8 | 3.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.8 | 3.2 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.8 | 7.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.8 | 2.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.8 | 78.4 | GO:0005604 | basement membrane(GO:0005604) |
0.8 | 2.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.7 | 2.2 | GO:0043218 | compact myelin(GO:0043218) |
0.7 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.7 | 2.8 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.7 | 5.5 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.7 | 2.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 2.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.7 | 7.3 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.7 | 3.3 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 6.5 | GO:0097413 | Lewy body(GO:0097413) |
0.7 | 4.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 1.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.6 | 2.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.6 | 3.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.6 | 8.9 | GO:0008091 | spectrin(GO:0008091) |
0.6 | 24.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 1.9 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.6 | 6.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 12.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 1.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.6 | 4.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 13.4 | GO:0031105 | septin complex(GO:0031105) |
0.6 | 4.9 | GO:0035976 | AP1 complex(GO:0035976) |
0.6 | 2.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.6 | 21.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 10.6 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.6 | 4.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.6 | 46.3 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 4.6 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.6 | 1.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.6 | 15.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 5.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.6 | 0.6 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.6 | 17.6 | GO:0005685 | U1 snRNP(GO:0005685) |
0.5 | 11.5 | GO:0042641 | actomyosin(GO:0042641) |
0.5 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.5 | 19.8 | GO:0043034 | costamere(GO:0043034) |
0.5 | 40.2 | GO:0030175 | filopodium(GO:0030175) |
0.5 | 12.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 1.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 4.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.5 | 1.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.5 | 1.6 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 7.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.5 | 2.5 | GO:0036128 | CatSper complex(GO:0036128) |
0.5 | 1.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 8.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.5 | 1.5 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.5 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 46.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.5 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.5 | 4.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.5 | 1.8 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.5 | 0.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 0.9 | GO:0044308 | axonal spine(GO:0044308) |
0.4 | 8.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.4 | 3.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.4 | 5.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.7 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.4 | 113.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.4 | 6.2 | GO:0030478 | actin cap(GO:0030478) |
0.4 | 1.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.4 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.4 | 5.7 | GO:0032432 | actin filament bundle(GO:0032432) |
0.4 | 2.4 | GO:0014802 | terminal cisterna(GO:0014802) |
0.4 | 3.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.4 | 14.5 | GO:0045178 | basal part of cell(GO:0045178) |
0.4 | 1.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.4 | 2.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.4 | 1.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 2.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.4 | 4.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 46.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 10.0 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 6.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 3.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.4 | 3.0 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 4.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 66.0 | GO:0001726 | ruffle(GO:0001726) |
0.4 | 1.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.4 | 7.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.4 | 19.5 | GO:0005901 | caveola(GO:0005901) |
0.4 | 23.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.4 | 15.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.4 | 4.0 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 1.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.4 | 4.3 | GO:0033643 | host cell part(GO:0033643) |
0.4 | 5.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.4 | 3.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.4 | 2.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.3 | 25.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.3 | 2.1 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 2.4 | GO:0031045 | dense core granule(GO:0031045) |
0.3 | 1.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.3 | 8.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.3 | 2.9 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 3.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 6.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.3 | 0.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.3 | 0.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.3 | 1.9 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 3.7 | GO:0030016 | myofibril(GO:0030016) |
0.3 | 1.8 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 7.6 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 2.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.3 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 1.2 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.3 | 7.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.3 | 0.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.3 | 12.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 24.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 1.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 0.9 | GO:0016938 | kinesin I complex(GO:0016938) |
0.3 | 3.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 1.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.3 | 17.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 1.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 1.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 3.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 2.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 117.1 | GO:0005924 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) |
0.3 | 0.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.3 | 1.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 2.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.3 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 3.2 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 40.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 19.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 1.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 25.4 | GO:0005814 | centriole(GO:0005814) |
0.2 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.2 | 13.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 5.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 6.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 2.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.2 | 1.6 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 3.2 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 0.7 | GO:0031430 | M band(GO:0031430) |
0.2 | 0.2 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.2 | 0.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.2 | 0.8 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.2 | 6.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 14.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 0.6 | GO:0000806 | Y chromosome(GO:0000806) |
0.2 | 4.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.2 | 2.5 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.2 | 9.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 1.2 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.2 | 0.8 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 1.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.2 | 2.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 0.4 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.2 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 0.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.2 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 20.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 4.8 | GO:0016460 | myosin II complex(GO:0016460) |
0.2 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.2 | 2.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.2 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 4.4 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 6.3 | GO:0005912 | adherens junction(GO:0005912) |
0.2 | 0.5 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.2 | 0.3 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 1.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 2.0 | GO:0030904 | retromer complex(GO:0030904) |
0.2 | 2.1 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.2 | 0.8 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 1.1 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 2.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 10.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.4 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.1 | GO:0042589 | zymogen granule(GO:0042588) zymogen granule membrane(GO:0042589) |
0.1 | 0.1 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.4 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 1.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.9 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.3 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 0.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.6 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.8 | GO:0097433 | dense body(GO:0097433) |
0.1 | 6.0 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 15.7 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 1.4 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 5.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 4.7 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 8.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.1 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 2.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 5.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 1.0 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 4.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 5.3 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.6 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
0.1 | 1.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.0 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 47.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.3 | GO:0060076 | excitatory synapse(GO:0060076) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 1.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.5 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 2.0 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 2.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.1 | GO:0030992 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.1 | 5.1 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.1 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.1 | 4.4 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.3 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 10.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.1 | 0.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 3.6 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 2.6 | GO:0031256 | leading edge membrane(GO:0031256) |
0.1 | 0.8 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
0.1 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 8.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 1.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.1 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
0.1 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 2.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 0.3 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 49.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.0 | 0.2 | GO:0071010 | U2-type prespliceosome(GO:0071004) prespliceosome(GO:0071010) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.1 | GO:0031674 | I band(GO:0031674) |
0.0 | 1.0 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.0 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.0 | 0.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 22.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 10.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0098791 | Golgi subcompartment(GO:0098791) |
0.0 | 18.2 | GO:0005856 | cytoskeleton(GO:0005856) |
0.0 | 0.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |